Breast Imaging

Why Is Imaging Usually Not Needed for Physiologic Nipple Discharge?

·
Why Is Imaging Usually Not Needed for Physiologic Nipple Discharge?

A 38-year-old female presents to your clinic with a six-month history of bilateral, milky nipple discharge, which she can express with manipulation but does not occur spontaneously. Her clinical examination is unremarkable, with no palpable masses, skin changes, or axillary lymphadenopathy. You are considering the next steps in her workup and whether breast imaging is warranted. This scenario, where the clinical features strongly suggest a physiologic origin, requires a careful approach to avoid unnecessary procedures and patient anxiety. For this specific presentation of physiologic nipple discharge in an adult, the American College of Radiology (ACR) Appropriateness Criteria state that initial imaging with breast ultrasound (US) is Usually not appropriate. This article will detail the clinical workflow, the rationale for withholding imaging, and the appropriate next steps for this common presentation.

Who Fits This Clinical Scenario?

This guidance applies to adult patients—female, male, transfeminine, or transmasculine—presenting with nipple discharge that has clear physiologic characteristics. The key features that define physiologic discharge are that it is typically bilateral, involves multiple ducts, and is non-spontaneous (requiring compression or stimulation to be expressed). The fluid itself is often milky (galactorrhea), but can also be yellow, green, brown, or gray. A thorough clinical history and physical examination are paramount to correctly categorizing the discharge.

This workflow is specifically for patients whose presentation aligns with a physiologic etiology. It is crucial to distinguish this from scenarios that require a different, more urgent imaging pathway. This guidance does not apply if the patient presents with features of pathologic discharge, such as:

  • Unilateral and spontaneous discharge: Fluid expressed from a single breast without any manipulation.
  • Single-duct origin: Discharge that can be traced to one specific duct opening on the nipple.
  • Bloody (sanguineous), clear (serous), or pink (serosanguinous) fluid.
  • Association with a palpable breast mass.

Patients with these findings, regardless of age or gender identity, fall into different clinical scenarios, such as the workup for pathologic nipple discharge, which mandates initial imaging.

What Diagnoses Are You Working Up in This Scenario?

When nipple discharge is determined to be physiologic, the diagnostic focus shifts away from structural breast pathology and toward systemic or benign local causes. The goal of the workup is not to find cancer, as the risk is exceedingly low, but to identify the underlying reason for the discharge.

The most common cause is galactorrhea, the secretion of milky fluid unrelated to pregnancy or breastfeeding. This is often driven by hyperprolactinemia, which can result from a pituitary adenoma (prolactinoma), hypothyroidism (due to elevated TRH stimulating prolactin), or, most frequently, medications. A wide range of drugs, including certain antipsychotics, antidepressants (SSRIs, tricyclics), and antihypertensives, can elevate prolactin levels and induce discharge.

Another common consideration is duct ectasia, a benign condition where a milk duct widens and its walls thicken, potentially leading to fluid blockage and a sticky, green, or black discharge. While it can sometimes present unilaterally, bilateral and multi-ductal expression is common and considered a physiologic variant.

Finally, fibrocystic changes can cause nipple discharge. These non-cancerous changes can lead to fluid accumulation in cysts that may be expressed from the nipple. This is a very common finding, particularly in premenopausal women, and is considered part of the spectrum of normal breast physiology.

Why Is Imaging Usually Not Appropriate for This Presentation?

For a patient with clinically physiologic nipple discharge, the ACR rates breast ultrasound, diagnostic mammography, and breast MRI as Usually not appropriate. The rationale is rooted in balancing the extremely low pre-test probability of malignancy against the high probability of false-positive findings from sensitive imaging modalities.

In the absence of pathologic features (e.g., unilateral, spontaneous, bloody discharge, or a palpable mass), the likelihood of an underlying breast cancer is negligible. Ordering imaging in this low-risk population does little to improve cancer detection but significantly increases the chance of identifying incidental, benign findings. These “incidentalomas,” such as simple cysts or benign-appearing nodules, can trigger a cascade of further imaging, unnecessary anxiety, and potentially invasive procedures like biopsies, all with no ultimate benefit to the patient.

Let’s examine the specific modalities:

  • US breast: While non-invasive and free of ionizing radiation (0 mSv), its high sensitivity can detect many clinically insignificant findings. In this scenario, it is rated Usually not appropriate because the risk of a false-positive result outweighs the near-zero chance of finding a malignancy causing the physiologic discharge.
  • Mammography diagnostic / Digital breast tomosynthesis diagnostic: These modalities use ionizing radiation (Relative Radiation Level ☢☢, 0.1-1 mSv) and are the cornerstones of screening and diagnostic evaluation for breast cancer. However, for physiologic discharge without other concerning findings, they are also rated Usually not appropriate. They add little diagnostic value for the discharge itself and carry the same risk of incidental findings, along with a small radiation dose.
  • MRI breast without and with IV contrast: This is the most sensitive test for breast cancer but has the highest rate of false positives. It is correctly reserved for high-risk screening or specific problem-solving and is Usually not appropriate for evaluating physiologic discharge.

The clinical examination is the most powerful tool in this scenario. A confident clinical diagnosis of physiologic discharge is sufficient to guide the next steps, which are clinical, not radiological.

What’s Next After the Clinical Exam? Downstream Workflow

Once you have confidently classified the nipple discharge as physiologic based on history and physical exam, the workflow shifts from breast imaging to clinical and laboratory evaluation.

  • If the discharge is milky (galactorrhea): The appropriate next step is a laboratory workup. This should include a serum prolactin level, a Thyroid-Stimulating Hormone (TSH) level to rule out hypothyroidism, and a pregnancy test (hCG) in individuals of childbearing potential. A thorough medication review is also critical to identify and potentially substitute any offending drugs. If prolactin is significantly elevated, this may prompt a referral to endocrinology and subsequent imaging of the pituitary gland (MRI), not the breast.
  • If the discharge is non-milky but clearly physiologic: Reassurance is the primary intervention. Patients should be educated on the benign nature of the findings and advised to avoid frequent nipple stimulation, which can perpetuate the discharge. No further workup is typically needed unless the character of the discharge changes.
  • When to re-evaluate: The patient should be instructed to return if the discharge changes character. If it becomes spontaneous, unilateral, bloody, or is accompanied by a new palpable lump, the presentation has shifted. At that point, the patient would no longer fit this scenario and would instead be managed according to the ACR Appropriateness Criteria for pathologic nipple discharge, where imaging is indicated.

Pitfalls to Avoid (and When to Get Help)

In managing physiologic nipple discharge, several common pitfalls can lead to unnecessary testing and patient anxiety.

  • Misclassifying the discharge: The most critical error is failing to elicit the key features that distinguish physiologic from pathologic discharge. Always ask specifically about bilaterality, spontaneity, color, and whether it comes from a single duct or multiple.
  • Ordering imaging due to patient anxiety: While it can be tempting to order an ultrasound for reassurance, this often backfires when incidental findings are discovered. A clear explanation of why imaging is not recommended is a more effective and appropriate reassurance tool.
  • Overlooking medication side effects: Always perform a meticulous review of the patient’s current medications, including over-the-counter supplements, as this is a very common and reversible cause of galactorrhea.
  • Forgetting the endocrine workup: For milky discharge, failing to check prolactin and TSH levels means missing the most common underlying systemic causes.

If prolactin levels are significantly elevated without a clear pharmacologic cause, or if there is any clinical uncertainty, an endocrinology consultation is the appropriate next step.

Related ACR Topics and Tools

For a comprehensive overview of all clinical scenarios related to this topic, please see our parent guide. For further exploration of adjacent criteria or imaging techniques, the following resources are available.

Frequently Asked Questions

What if a patient with physiologic discharge is very anxious and insists on imaging for reassurance?

Patient education is key. Explain that in this specific clinical situation, the risk of finding a clinically insignificant ‘incidentaloma’ on an ultrasound is much higher than the risk of finding a cancer. This can lead to a cascade of more tests and biopsies that are ultimately unnecessary. Reassure them that a thorough clinical exam is the most reliable tool for this presentation and that imaging is not recommended by expert guidelines because it often causes more harm than good.

Does this guidance apply to transmasculine patients on testosterone therapy?

Yes, this guidance applies. A transmasculine patient with bilateral, non-spontaneous, multi-ductal discharge would be managed the same way. While breast tissue is reduced after chest reconstruction surgery, residual glandular tissue can remain. The principles of distinguishing physiologic from pathologic discharge still hold. If the discharge has pathologic features, an imaging workup would be appropriate.

What are the most common medications that cause physiologic nipple discharge?

A wide variety of medications can cause hyperprolactinemia and subsequent galactorrhea. The most common culprits include dopamine antagonists like antipsychotics (e.g., risperidone, haloperidol) and anti-emetics (e.g., metoclopramide). Certain antidepressants, particularly SSRIs and tricyclics, as well as some antihypertensives like verapamil and methyldopa, are also frequently implicated.

At what point should I become concerned that a physiologic discharge has become pathologic?

You should advise the patient to return for re-evaluation if any ‘red flag’ features develop. The key warning signs are if the discharge becomes: 1) Spontaneous (occurs without stimulation), 2) Unilateral (from one breast only), 3) Localized to a single duct, 4) Bloody or clear/watery, or 5) Is accompanied by a new palpable lump, skin dimpling, or nipple retraction. The development of any of these features warrants a new clinical assessment and initiation of an imaging workup for pathologic discharge.

Is any imaging ever appropriate for physiologic nipple discharge?

For the nipple discharge itself, no. However, the patient should continue to follow standard, age-appropriate breast cancer screening guidelines. For example, a 45-year-old female with physiologic discharge should still undergo her routine screening mammogram. The screening study is being done based on her age and risk factors, not as a workup for the benign discharge.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026